An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway
about
Computationally Modeling Lipid Metabolism and Aging: A Mini-reviewAn in silico model of retinal cholesterol dynamics (RCD model): insights into the pathophysiology of dry AMDSystems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile InfectionEfficient Generation and Selection of Virtual Populations in Quantitative Systems Pharmacology Models.In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.A Six-Stage Workflow for Robust Application of Systems Pharmacology.Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.Quantitative Systems Pharmacology: A Case for Disease Models.A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics.Analysis of "On/Off" Kinetics of a CETP Inhibitor Using a Mechanistic Model of Lipoprotein Metabolism and Kinetics.Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach.Kinetic modeling and the rise of systems pharmacology.Leveraging model-informed approaches for drug discovery and development in the cardiovascular space.In vivo and in silico dynamics of the development of Metabolic Syndrome.
P2860
Q28087689-79532936-038C-4797-8D24-1B44610A3C84Q33867675-EF81D024-FE0D-4F1F-8164-68F95D3E6270Q35729663-99AD1A37-A465-4E25-877B-FEF569BB45B9Q36734135-0A25EB74-CB82-440E-8CF2-EEDCAAD003E4Q36843279-6F0ADBE8-08C0-4DAB-A560-F9BB6DAA4681Q36933677-70FF58CC-8887-482C-9DDB-E3E6D41AF3FEQ38420505-BFCAB955-2D1E-483D-9F78-64C495D2CE8FQ40889594-6E3B28D5-37B6-4ADB-B5D9-C8B61B4E060FQ41043010-B56A3B04-6461-4217-9017-F46037090C46Q41946360-702CB53C-9B19-447A-A969-3AEF71691371Q42131230-97F0A74D-7DF4-4170-A3A4-12DED1EA0DAAQ42661877-3B712E5E-8D0B-44EE-A284-DE23E28E2EDEQ48201953-A05BC1B3-5B37-4ED3-8A16-8A8EE28E0AFDQ55166354-CE399691-6AE2-4EBB-A0CF-3B9EFF682782
P2860
An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An in-silico model of lipoprot ...... cholesterol transport pathway
@ast
An in-silico model of lipoprot ...... cholesterol transport pathway
@en
An in-silico model of lipoprot ...... cholesterol transport pathway
@nl
type
label
An in-silico model of lipoprot ...... cholesterol transport pathway
@ast
An in-silico model of lipoprot ...... cholesterol transport pathway
@en
An in-silico model of lipoprot ...... cholesterol transport pathway
@nl
prefLabel
An in-silico model of lipoprot ...... cholesterol transport pathway
@ast
An in-silico model of lipoprot ...... cholesterol transport pathway
@en
An in-silico model of lipoprot ...... cholesterol transport pathway
@nl
P2093
P2860
P3181
P1476
An in-silico model of lipoprot ...... cholesterol transport pathway
@en
P2093
Eliot A Brinton
M Nazeem Nanjee
Norman A Mazer
P2860
P304
P3181
P356
10.1371/JOURNAL.PCBI.1003509
P407
P577
2014-03-01T00:00:00Z